RT @EuroELSO: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/IkCKI13ZLZ This trial revisited r…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @KlgiaRespCrit: This is the end 🎶The bloking end... the end🎶 #PETALnetwork https://t.co/ubiPhiQoPa
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @EuroELSO: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/IkCKI13ZLZ This trial revisited r…
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
Important trial, but why wasn’t proning part of the protocol in both arms? Only 15% of participants were proned compared to 90% of control arm in EOLIA. Given the impressive survival benefit in PROSEVA, proning in severe ARDS should be standard of care.
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
ok .. so we can lighten them up now :-)
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
RT @yodagreenemd: Ya mejor que nos cargue el payaso... Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https…
This is the end 🎶The bloking end... the end🎶 #PETALnetwork https://t.co/ubiPhiQoPa
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
No benefit to early paralysis in ARDS. https://t.co/aC94eeTTCk
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @DocMusician: Bloqueo neuromuscular en SIRA, que dijo mi mamá que siempre no :( https://t.co/RhbamyQlXr
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @AltshulerDiana: Almost a decade later after the ACURASYS study the PETAL study shows no benefit to neuromuscular blockade in early ARD…
RT @JBLascarrou: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/7LaTusuqsL
It’s common practice to paralyze our mod-sev ARDS pts based on the ACURASYS trial. The results of this study question this practice. Interesting. 🧐
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Agreed. Honored to even be in the small print with this team. @NEJM
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
RT @mgdrake: Huge congrats to my colleague @bronchoscope for his tireless commitment to his patients and to this study. Could not have bee…
#ATS2019 Let the twitter conversation begin!
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
Interested in twitter response to this #NMBA #ARDS #ICU @SMHCoeMV Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/Vg1HvXDtHy
RT @AltshulerDiana: Almost a decade later after the ACURASYS study the PETAL study shows no benefit to neuromuscular blockade in early ARD…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
Hi #medtwitter #FOAMcc #FOAMed! Join us for our 2nd tweet meet on May 26 9 PM central time & May 27 9 PM IST to discuss the ROSE trial *hot off the press* Please retweet and follow! https://t.co/FL7cbzfh8v https://t.co/4926ZbFwXH
Ya mejor que nos cargue el payaso... Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/X72lw5fUB9
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
Este ensayo revisó la investigación realizada hace aproximadamente una década que mostró un beneficio de supervivencia con el bloqueo neuromuscular temprano en pacientes con SIRA https://t.co/yy4tpYVM91
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/IkCKI13ZLZ This trial revisited research conducted about a decade ago. #ATS2019 /1
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
Very wise
Resultados del bloqueo neuromuscular en SDRA. Todos los tratamientos deben ser personalizados
Bloqueo neuromuscular en SIRA, que dijo mi mamá que siempre no :(
RT @JBLascarrou: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/7LaTusuqsL
Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA.
RT @ipeltan: Proud to be a (small) part of the @nih_nhlbi PETAL Network team that just reported the ROSE trial of NMB for #ARDS in @NEJM ht…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
logo-60 https://t.co/w7ZsQBdMdG
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/S5jPscsf6B /1
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Almost a decade later after the ACURASYS study the PETAL study shows no benefit to neuromuscular blockade in early ARDS vs. light sedation with same vent strategies! 😳
Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after all Thoughts @JohnGreenwoodMD @emcrit @EMNerd_ @WICSBottomLine https://t.co/l5M3JXtGMP
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Huge congrats to my colleague @bronchoscope for his tireless commitment to his patients and to this study. Could not have been done without him @OHSUPulmCCM https://t.co/XmLyOeuafJ
RT @ATSCritCare: Read the full trial: https://t.co/8tvh1Qngy9
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM. Interesting that driving pressure was less in control group due to more liberal peep. This may have offset benefit of NMBs. Does this change your practice? https://t.co/nWpMRUR
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という結果です。ACURASYSとは異なる結果ですね。 https://t.co/VrJpAJB442 https://t.co/VrJpAJB442
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
Proud to be a (small) part of the @nih_nhlbi PETAL Network team that just reported the ROSE trial of NMB for #ARDS in @NEJM https://t.co/Er3Ic1VjaP https://t.co/hyKgSb1hjp
The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients. Trials are hard & extremely labor intensive. I applaud their efforts, but I hope we can find ways to improve efficiency #ats201
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit and modestly more problems in paralyzed patients #ATS2019
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…